Kelly Lawrence W & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-8
Closed -$2.21K – 167
2024
Q4
$2.21K Hold
8
– – ﹤0.01% 158
2024
Q3
$2.77K Hold
8
– – ﹤0.01% 160
2024
Q2
$2.65K Hold
8
– – ﹤0.01% 166
2024
Q1
$2.91K Hold
8
– – ﹤0.01% 168
2023
Q4
$2.4K Hold
8
– – ﹤0.01% 162
2023
Q3
$2.29K Hold
8
– – ﹤0.01% 155
2023
Q2
$2.16K Hold
8
– – ﹤0.01% 149
2023
Q1
$2.04K Hold
8
– – ﹤0.01% 154
2022
Q4
$2.65K Hold
8
– – ﹤0.01% 152
2022
Q3
$2K Hold
8
– – ﹤0.01% 167
2022
Q2
$2K Buy
+8
New +$2.06K ﹤0.01% 166

Other funds holding CI

Kelly Lawrence W & Associates's CI Position: Q1 2025 in Review

Kelly Lawrence W & Associates sold out of Cigna (CI) in Q1 2025, closing a stake of 8 shares — an estimated $2.21K sold.

Kelly Lawrence W & Associates first reported a position in CI in Q2 2022 and held it in 11 quarters. The position peaked at $2.91K in Q1 2024. 1,698 funds tracked by Wall St. Rank hold CI as of Q1 2025.

  • Kelly Lawrence W & Associates reported no remaining Cigna position as of Q1 2025 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 8 Cigna shares in Q1 2025, an estimated $2.21K.
  • Kelly Lawrence W & Associates first reported a position in Cigna in Q2 2022 and held it in 11 quarters.
  • Kelly Lawrence W & Associates's Cigna position peaked at $2.91K in Q1 2024.
  • 1,698 funds tracked by Wall St. Rank held Cigna as of Q1 2025.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2025, filed 14 May 2025.